Google DeepMind has reportedly restricted on sharing research will stifle AI innovation, warns the CEO of Iris.ai, one of ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...